Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Anpac Bio-Medical Science, Applied DNA Sciences, Argentum Medical, Ascendum Solutions, Beckman Coulter, Bone Therapeutics, Casetabs, Contakt World Technologies, Dnanudge, Exergen, Foshion Dental, GE Healthcare, Genesiscare, Genosity, GT Medical Technologies, Hologic, Hst Pathways Systems & Technologies, Igentify, Intervenn Biosciences, Iremedy Healthcare Companies, Logicink, Luxcreo, Oxford Immunotec Global, Penumbra, Precision Genetics, Promaxo, Rapid AI, Speedx, Tscan Therapeutics, Wheeler Labs.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Allurion Technologies, Axonics, Surmodics.

Med-tech firms raising money in public or private financings, including: Imagin Medical, Senseonics.

New hires and promotions in the med-tech industry, including: Dymicron, Imprivata, Sientra, Stryker.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Arcturus, Astrazeneca, Boehringer Ingelheim, Bridge, Capricor, Crescita, Generex, GPCR, Humanigen, Juyou, Metriopharm, Neoleukin, Novavax, Om, Ose Immunotherapeutics, Qualigen, Sichuan Clover, Taigen, Taiwan Liposome, Vir, Wuxi Apptec.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Asieris, Astellas, Basilea, Beigene, Eusa, Shenzhen China Resources Gosun, Lianbio, Novavax, Senhwa, Sorrento.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Betterlife, Clinigen, Emmaus, Forma, Immune-Onc, Lilly, Oryzon, Praxis, Rafael, Supernus.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: 180 Life Sciences, 3D, Abic, Agenus, Algae-C, Altimmune, Antibe, Applied Molecular, Aravive, Armis, Atyr, Axovant, Asymchem, Azurrx, Bach, Bone, Briacell, Brickbio, Caris, Cevec, Collplant, CSL Behring, Elevatebio, Guangzhou Baiyunshan, Helix, Hitgen, Insilico, Janssen, Kalos, Locus, Lonza, Mainpointe, Mallinckrodt, Merck, Mesentech, Point, Prelicel, Prestige, Qiagen, Recce, Renew, Roche, TCR2, Teva, Tscan, Valirx, Xphyto.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Affibody, Agenus, American Gene Tech, Amgen, Arena, Astrazeneca, Corvus, Curevac, Denali, Eisai, Galapagos, Hepion, Immunitybio, Immunophotonics, Kiniksa, Merck, Mitsubishi, Nantkwest, Nicox, Onxeo, PDS, Quest, Rallybio, Revance, Sanifit, Verrica.

Biopharmas raising money in public or private financings, including: Adagio, Arch, Coimmune, Destiny, Edoc, Therapeuticsmd.